Skip to main content

Publications

55 publications

Active

2 grants
  • MPI
    Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer
    NCI · 2022–2027 · via NIH RePORTER
    P50CA257881-05
  • MPI
    Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
    NCI · 2022–2027 · via NIH RePORTER
    R01CA262516-04
Completed grants (1)
  • MPI
    Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
    NCI · 2017–2022 · via NIH RePORTER
    U01CA224175-03